Dr. Xu Huji
徐沪济
Chief Physician; Professor; Director of Rheumatology and Immunology Department
Where they practice, who they consult.
- Changzheng Hospital, Naval Medical University (Second Military Medical University), Shanghai
- 30+ years in rheumatology and immunology
- English, Mandarin
What they personally lead.
Training and recognition
Pioneered the clinical application of CAR-T cell therapy for refractory autoimmune diseases in China, with groundbreaking results in patients with treatment-resistant lupus and inflammatory myopathy; established one of China's largest ankylosing spondylitis cohorts; led clinical trials on novel biologic agents for spondyloarthritis; served on multiple Chinese and international rheumatology expert committees; published in Nature Medicine, Annals of the Rheumatic Diseases, and Signal Transduction and Targeted Therapy
What to expect
Dr. Xu is a top choice for patients with severe ankylosing spondylitis or those interested in advanced cellular therapy approaches for refractory autoimmune conditions. His team at Changzheng Hospital is among the first in the world to offer CAR-T therapy for autoimmune diseases in a clinical setting.
Check the public record
Look up publications, citations, and academic profile on independent platforms before reaching out.
Results are automated searches and may include other individuals with similar names.
Ask the AI or request a coordinator.
The AI can compare Xu Huji's background to other specialists in Shanghai. A coordinator can confirm appointment availability and English-language support.
Information is provided for reference only and may not reflect current conditions. Verify directly with the hospital before making decisions.